Fossil fuel CO2 emissions increase again in 2024
Science Daily: Pharmacology News
NOVEMBER 12, 2024
Global carbon emissions from fossil fuels have reached a record high in 2024, according to new research.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Science Daily: Pharmacology News
NOVEMBER 12, 2024
Global carbon emissions from fossil fuels have reached a record high in 2024, according to new research.
Vial
MARCH 6, 2024
The field of clinical research is a dynamic and rapidly evolving one. One way to ensure that you are at the forefront of these developments is by attending clinical research conferences. In 2024, an array of these conferences are scheduled to take place across the world. Learn more on their website here.
Broad Institute
OCTOBER 23, 2024
Machine learning guides researchers to new synthetic genetic switches By Tom Ulrich October 23, 2024 Breadcrumb Home Machine learning guides researchers to new synthetic genetic switches A new method allows precise activation or repression of genes in specific cells and tissues. By Sarah C.P.
KIF1A
MAY 4, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. In this week’s article, researchers in Brazil identified a KIF1A mutation in a cohort of patients with congenital ataxia.
Broad Institute
OCTOBER 30, 2024
Researchers map communities of single cells in metastatic breast cancers By Corie Lok October 30, 2024 Breadcrumb Home Researchers map communities of single cells in metastatic breast cancers The team compared different single-cell and spatial profiling methods to explore the diversity of cells in metastatic breast cancer biopsies.
SCIENMAG: Medicine & Health
FEBRUARY 14, 2024
The 17th World Congress on Polyphenols Applications 2024, scheduled for September 19-20, 2024, at Università degli Studi di Milano Statale in Italy, has revealed its program. This congress aims to bridge the latest scientific research on polyphenols with their potential to promote health.
KIF1A
MARCH 2, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Studies like SPARK highlight the importance of human data in accelerating patient-facing research. Want to learn more about translational research?
KIF1A
APRIL 13, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Read the Article See the Little SENDsations website The post #ScienceSaturday: April 13, 2024 appeared first on KIF1A.
KIF1A
FEBRUARY 10, 2024
Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. And just like it can be challenging to play a new game without knowing all the rules, one hurdle for gene therapy research and development has been a lack of a playbook.
Elrig
MARCH 12, 2024
Steve’s Keynote: Supporting the UK’s globally competitive innovation ecosystem There is a fundamental shift in how life science research is being carried out, the computational tools are transforming early drug discovery which in turn leads to real chemistry, advanced diagnostics and innovative therapies.
KIF1A
MARCH 16, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Read the Article The post ScienceSaturday: March 16, 2024 appeared first on KIF1A.
Perficient: Drug Development
MAY 28, 2024
On Sunday, May 19th, 2024, 21 individuals consisting of Perficient employees and their family members, participated in the 2024 Michigan Kidney Walk at the Detroit Zoo. More than 80 cents of every dollar raised goes to research, patient services, professional education, public health education, and community services.
KIF1A
MARCH 9, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Ltd and was engaged in research related to the extraction and culture of stem cells and immune cells. program in Chemistry in the fall of 2024).
KIF1A
APRIL 6, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Her undergraduate research focused on lipid metabolism of NASH at UCSD Medical School and DNA breakage and repair mechanism at Scripps Research.
KIF1A
APRIL 20, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. In this week’s Review Article, researchers describe genetic neurodevelopmental disorders caused by axonal transport defects, including KAND.
KIF1A
FEBRUARY 24, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research A Model for Chemomechanical Coupling of Kinesin‑3 Motor Like humans, KIF1A pairs walk one step at a time, one foot in front of the other.
SCIENMAG: Medicine & Health
SEPTEMBER 7, 2023
HOUSTON, September 7, 2023 – The American Pediatric Society (APS) and the Society for Pediatric Research (SPR) are pleased to announce Donna M. Ferriero, MD, MS, as the 2024 Mary Ellen Avery Neonatal Research Award recipient.
KIF1A
MARCH 23, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. In this week’s article, researchers in Serbia expanded genetic testing for adult HSP patients.
Drug Target Review
JANUARY 23, 2024
What innovative approaches and technologies are anticipated to reshape immuno-oncology treatments in 2024? We anticipate this area to grow, especially cancer vaccines, with important read-outs expected across various cancer types in 2024. Espen integrates clinical and research expertise as Director of Medical Affairs.
Elrig
JANUARY 19, 2024
ELRIG Launches the TechBio Breakthrough Zone at Research & Innovation 2024 ELRIG Launches the TechBio Breakthrough Zone at Research & Innovation 2024 At ELRIG, we are always looking for ways to support the life sciences community. Register for Research & Innovation Conference 2024 as a delegate.
KIF1A
JANUARY 20, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. In this week’s article, researchers in Shanghai, China identified 6 children with KIF1A mutations and compared their symptoms to cases in the literature.
KIF1A
JANUARY 27, 2024
Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. This study also highlights the diversity of HSP types: across 18 patients, researchers identified 15 different spastic paraplegia subtypes.
LifeSciVC
JANUARY 16, 2024
Tirzepatide is also trialing in a Phase 3 obese HFpEF trial, and top-line readout in 2H 2024 will suggest whether the increased weight loss achieved with dual GLP1/GIPR modulation further improves QoL and functional endpoints. ALT) continue to build momentum in the indication. Will incretins “solve” MASH in obese patients?
Drugs.com
JULY 10, 2024
WEDNESDAY, July 10, 2024 -- A newly discovered hormone could help fight osteoporosis and quickly heal broken bones, researchers say. The research team identified Maternal Brain Hormone while trying to figure out why the bones of breastfeeding women.
Drugs.com
AUGUST 19, 2024
19, 2024 -- All 23 known species of the bacteria that cause Lyme disease have now been genetically mapped, providing an aid to better diagnosis and research."This MONDAY, Aug. This comprehensive, high-quality sequencing investigation of Lyme disease and.
Drugs.com
JULY 11, 2024
THURSDAY, July 11, 2024 -- Anorexia nervosa could be caused by lack of a specific brain chemical, reports a research team that has developed a possible cure for the eating disorder.Mouse studies have revealed that a deficit in acetycholine, a.
Perficient: Drug Development
AUGUST 19, 2024
We’re thrilled to announce that Perficient has been recognized as a 2024 Top Workplace by the Atlanta Journal-Constitution ! Every year, an anonymous survey conducted by a renowned research firm evaluates key aspects of the workplace, including organizational leadership, company values, career opportunities, work-life balance, and more.
NIOSH Science Blog: Drugs
JUNE 5, 2024
This blog highlights select research and prevention efforts from the National Institute for Occupational Safety and Health (NIOSH) and NSC in this year’s focus areas of safety engagement; roadway safety; risk reduction; and slips, trips and falls. For each week of the month, the National Safety Council (NSC) identifies a theme to focus on.
KIF1A
JANUARY 13, 2024
Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Want to see more research from the Vallee Lab? Read the Article The post #ScienceSaturday: January 13, 2024 appeared first on KIF1A.
NIOSH Science Blog: Drugs
APRIL 25, 2024
Exemplary science is the foundation for all National Institute for Occupational Safety and Health (NIOSH) research and prevention activities. This year’s Science and Service Awards took place on April 25, 2024. Each year, NIOSH recognizes outstanding science and service from our employees.
KIF1A
MAY 31, 2024
Our mission to accelerate research and find a cure for KIF1A Associated Neurological Disorder (KAND) remains our guiding light. Call to Action: Natural History Study Enrollment We urgently need your help to accelerate our research. 6/27 Fundraising Strategy Session : Join us to learn how you can help raise funds for our mission!
Perficient: Drug Development
JANUARY 9, 2024
Medical device industry trends for 2024. Let’s look at what is poised to impact the medical device industry in 2024. Let’s look at what is poised to impact the medical device industry in 2024. The medical device industry is in a constant state of evolution. population will be 65 and older by the year 2060.
Broad Institute
NOVEMBER 6, 2024
By Leah Eisenstadt November 6, 2024 Oncologist Kerry Reynolds (left) and researcher Alexandra-Chloé Villani (right) work together to better understand and treat complications of immunotherapy. We started by bringing in subspecialties to think about best practices for clinical care and to devise research questions to ask.
Alta Sciences
OCTOBER 28, 2024
Top Life Science Resources for Fall 2024 pmjackson Mon, 10/28/2024 - 17:59 There’s a lot of life science content out there, so for your convenience, we’ve curated a selection of expert insights, tips, case studies, and scientific and regulatory information. Image thumbnail_LifeScience_Fall-2024.jpg Read the eBook.
Drugs.com
MARCH 18, 2024
MONDAY, March 18, 2024 -- President Joe Biden plans to sign an executive order on Monday that will broaden the scope of medical research in women.The order "will direct the most comprehensive set of executive actions ever taken to expand and.
Broad Institute
NOVEMBER 21, 2024
Researchers identify source of a brain cancer’s deadly transformation By Corie Lok November 21, 2024 Breadcrumb Home Researchers identify source of a brain cancer’s deadly transformation Slow-growing glioma tumors become more aggressive when their cells shift identities and acquire new genetic mutations.
KIF1A
FEBRUARY 29, 2024
Today, on Rare Disease Day , let’s all band together to reach out to our state’s Federal Senators and Representatives to ask for funding for rare disease research and for genetic testing to be available to all (without having to fight your insurance company.) This month KIF1A.ORG held its first Board Meeting of 2024!
Drug Channels
FEBRUARY 9, 2024
Nasir shares findings from CareMetx’s new 2024 Patient Services Report research study: Revealing Manufacturer Priorities: Patients Naturally Take Center Stage. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Nasir also discusses how hub selection criteria are evolving.
Fierce BioTech
MARCH 12, 2024
Listing Image PPD-TF-logo.png Listing Introduction Get the latest FSP trends, strategies, and projections for biopharma and biotech companies as Lori Boyce, Vice President, PPD FSP Solutions, and Mike Lydon, Director, PPD FSP Solutions, share findings from The 2024 FSP Trends Report. On Demand Start Date Thu, 04/11/2024 - 12:00
Drugs.com
FEBRUARY 22, 2024
22, 2024 -- First Lady Jill Biden on Wednesday announced $100 million in federal funding to fuel research into women's health.“We We will build a health care system that puts women and their lived experiences at its center,” Biden.
keypoint
JULY 25, 2024
On September 10, 2024, Keystone Symposia will host a free ePanel event featuring the recipients of the Michelson Philanthropies & Science Prize for Immunology. The goal of the prize is to accelerate immunology advances with trans-disease applications towards vaccine and immunotherapy innovation.
SCIENMAG: Medicine & Health
MARCH 29, 2024
BOSTON, United States — 29 March, 2024 — Based on the success of its 2023 HF-GRO program effort, Hevolution Foundation is issuing a call for applications for the 2024 iteration of the program. HF-GRO is an international effort to accelerate progress in healthy aging research.
Broad Institute
MARCH 19, 2024
Researchers roll out a more accurate way to estimate genetic risks of disease By Claire Hendershot March 19, 2024 Breadcrumb Home Researchers roll out a more accurate way to estimate genetic risks of disease Two new approaches for generating polygenic scores demonstrate that compiled data improves score accuracy.
PPD
NOVEMBER 30, 2023
These shifts are a prelude to further change and progress in the clinical trial landscape in 2024. To get a pulse on the changing industry, the PPD clinical research business of Thermo Fisher Scientific surveyed 150 biotech and biopharma leaders for the second year in a row to illuminate industry trends, challenges and sentiments.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content